| |
| |
|
| Insider
Information: |
Ajer Jeffrey Robert |
| Relationship: |
Director |
| City: |
Novato |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
100,920 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$5,977,498 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
100,920 |
|
|
| Total
Value |
$5,977,498 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
3
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -1.4%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Biomarin Pharmaceutical Inc |
BMRN |
EVP, Chief Commercial ... |
2024-05-02 |
66,767 |
|
0 |
Premium* |
|
|
Nektar Therapeutics |
NKTR |
Director |
2023-09-18 |
34,153 |
2017-09-19 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
174 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 5 of 7
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2018-10-03 |
4 |
AS |
$98.98 |
$98,985 |
D/D |
(1,000) |
49,135 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2018-11-14 |
4 |
AS |
$91.62 |
$829,359 |
D/D |
(9,000) |
49,135 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2018-11-14 |
4 |
OE |
$63.10 |
$567,900 |
D/D |
9,000 |
58,135 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2019-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
12,557 |
61,692 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2019-03-01 |
4 |
D |
$94.76 |
$86,895 |
D/D |
(917) |
60,775 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2019-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
9,370 |
62,976 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2019-03-15 |
4 |
D |
$94.53 |
$677,686 |
D/D |
(7,169) |
53,606 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2019-03-19 |
4 |
AS |
$93.07 |
$346,965 |
D/D |
(3,728) |
59,248 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2019-03-21 |
4 |
AS |
$89.62 |
$406,634 |
D/D |
(4,519) |
54,729 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2019-03-22 |
4 |
D |
$88.05 |
$316,804 |
D/D |
(3,598) |
51,131 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2019-03-26 |
4 |
AS |
$89.18 |
$326,025 |
D/D |
(3,656) |
47,475 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2019-04-30 |
4 |
A |
$68.78 |
$21,254 |
D/D |
309 |
61,994 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2019-06-05 |
4 |
A |
$0.00 |
$0 |
D/D |
14,160 |
61,635 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
Director |
– • – |
2019-09-20 |
4 |
AS |
$20.24 |
$45,540 |
D/D |
(2,250) |
18,250 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
Director |
– • – |
2019-09-25 |
4 |
A |
$0.00 |
$0 |
D/D |
6,500 |
24,750 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
Director |
– • – |
2019-09-30 |
4 |
AS |
$18.06 |
$42,893 |
D/D |
(2,375) |
22,375 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2020-03-03 |
4 |
A |
$0.00 |
$0 |
D/D |
9,586 |
71,530 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2020-03-13 |
4 |
D |
$84.50 |
$645,918 |
D/D |
(7,644) |
63,886 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2020-03-16 |
4 |
A |
$0.00 |
$0 |
D/D |
10,380 |
74,266 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2020-03-20 |
4 |
D |
$73.05 |
$262,907 |
D/D |
(3,599) |
70,667 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2020-03-24 |
4 |
AS |
$74.36 |
$151,769 |
D/D |
(2,041) |
68,626 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2020-03-25 |
4 |
AS |
$78.47 |
$126,964 |
D/D |
(1,618) |
67,008 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2020-04-01 |
4 |
AS |
$82.00 |
$126,034 |
D/D |
(1,537) |
65,471 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2020-04-08 |
4 |
AS |
$79.98 |
$192,512 |
D/D |
(2,407) |
63,064 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2020-04-30 |
4 |
A |
$62.59 |
$21,154 |
D/D |
338 |
63,402 |
0 |
- |
|
174 Records found
|
|
Page 5 of 7 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
